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Abstract
The Borrelial resurge demonstrates that B. burgdorferi is a persistent health problem. This spirochaete is responsible for a global public health concern called Lyme disease. B. burgdorferi faces diverse environmental conditions of its vector and host during its life cycle. To circumvent the host immune system is a prominent feature of B. burgdorferi. To date, numerous studies have reported on the various mechanisms used by this pathogen to evade the host defense mechanisms. This current review attempts to consolidate this information to describe the immunological and molecular methods used by B. burgdorferi for its survival.  
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1: Introduction
Borrelia burgdorferi, a spirochaete, is a vector born pathogen that causes Lyme borreliosis. Borrelia burgdorferi sensu lato is a complex of spirochetes consisting of different Borrelia species. Among the 20 Borrelia species of B. burgdorferi sensu lato (s.l.) complex transmitted by ixodid ticks, B. burgdorferi, B. garinii, B. spielmanii, B. afzelii, and B. bavariensis (formerly known as B. garinii OspA serotype four), are known to cause human Lyme disease  ADDIN EN.CITE []. The various phases of infection in Lyme borreliosis include localized infection, early disseminated infection and latent phase []. The genome of B. burgdorferi is devoid of any known toxins or machinery required for their secretion  ADDIN EN.CITE []. However spirocheates, especially Treponema pallidum and B. burgdorferi, both contain secretory systems named SecY Tpa (450 gij7444758) and SecY Bbu (434 gij3914976) (sp|O51451), respectively []. It is assumed that infection or disease is mediated by the host inflammatory response []. Erythma migrans (EM) is the first pathognomonic skin lesion to Borrelia infection. Circulation through blood happens very transiently. The host demonstrates a local inflammatory and immunological response against tick saliva [], however substances present in tick saliva possess anti-inflammatory and anti-hemostatic properties which overcome these responses []. Prominent signs of late-stage illness include arthritis and neurological impairment []. B. burgdorferi has to evade host defenses for its survival.
For survival, this spirochaete synthesizes suitable proteins to cycle between two diverse environments of the tick vector and vertebrate host. Various isolates of Borrelia demonstrate significant phenotypic and genetic diversity []. Moreover there exists a substantial variability among various isolates of B. burgdorferi  on the basis of protein profiling []. Several studies have investigated the host immune response  ADDIN EN.CITE [] but mechanisms of immune evasion used by this spirochaete are still largely unknown.
This current review describes the various immunological and molecular strategies taken by the B. burgdorferi to subsist during its diverse cycle. Under the caption of immunology, we summarize mechanisms adapted by Borrelia to evade and manipulate innate and adaptive immune responses of its vertebrate host. We have also listed some vital proteins of B. burgdorferi, alongside their function and expression during different stages of its enzootic cycle. Furthermore, molecular tactics espoused by B burgdorferi to fend off host immunity are discussed in the review.
1.1: General description:
B. burgdorferi is a fastidious microorganism that requires additional nutrients to survive. It may stain as Gram-negative bacteria but it is neither a true Gram-positive nor Gram-negative bacterium  ADDIN EN.CITE []. Borrelia was isolated from Ixodes ticks in 1980s []. Similar to Treponema spp., B burgdorferi is a flat wave bacterium [] 20–30 µm in length, 0.09- 0.75µm in diameter, and microaerophilic in nature []. Due to its double-membrane complex structural arrangement, it stains feebly and is generally visualized under dark field or phase contrast microscopy. It has 7-11 periplasmic flagella that alter the chemiosmotic potential into motive force [], and a protoplasmic cylinder that holds the cytoplasm. The outer membrane (OM) is a fragile double-layered structure lacking lipopolysaccharides  ADDIN EN.CITE []. Key lipid components of OM include phosphatidylcholine and phosphatidylglycerol. Other glycolipids such as cholesteryl-β-D-galactopyranoside and cholesteryl-6-O-acyl-β-D-galactopyranoside [], which possess immunogenic properties, are the key elements of OM. Typical bacteria are devoid of these elements. A range of lipoproteins that decorate its outer surface is the primary difference accounting pathogenesis of B. burgdorferi infection. Akin to proteobacteria, B. burgdorferi also has lipoprotein outer-membrane localization (LOL) system that directs lipoproteins towards the outer membrane. However, the LOL system of Borrelia works in complete contrast to that of the E. coli prototype []. B. burgdorferi  lacks the usual pathway for translocation of lipoproteins to the outer surface []. There is some evidence that a fundamental element of outer-membrane-assembly machinery of the B. burgdorferi  is BamA (β-barrel assembly machinery A) ortholog []. In Gram-negative bacteria, lipoproteins are sorted to the OM by LolB, which is absent in Borrelia.
Among all known bacteria, Borrelia possesses the most intricate genome []. Genomics of B31 B. burgdorferi revealed about 20 or more discrete genetic elements. It has a small genome of 1·5 Mb  ADDIN EN.CITE []. A linear chromosome of about 1 Mb is the main player of its genome. Most of the housekeeping genes reside on this chromosome (Fig: 1). In addition to this chromosome, Borrelia has twenty one plasmids (12 linear and 9 circular). This is the highest number of plasmids retained by any bacterium []. Plasmids are the primary location for some of the vital genes responsible for pathogenicity. These plasmids which encode outer surface proteins (Osps), display a great deal of variability in gene content of different strains.
1.2: Maintenance of B. burgdorferi in nature: 
B. burgdorferi s.l. maintains its complex transmission network with the help of a hard tick and a competent reservoir vertebrate host. These reservoir hosts include insectivores, rodents and different species of bird []. Therefore, B. burgdorferi s.l. may be considered as a group of several ecotypes []. A point to consider is that the primary tick vectors in Asia, Europe and the United States i.e. Ixodes ricinus, Ixodes scapularis and Ixodes persulcatus, are the generalist ectoparasites; meaning they feed on various vertebrate hosts. This general nature of ticks creates different probabilities for the transmission between different hosts, potentially associating various ecological niches of Borrelia []. Immature ticks (larval and nymphal ticks) maintain Lyme borreliosis in nature by feeding on the same set of competent reservoir hosts. Borrelia typically spends 1 to 3 months in vertebrate host before being transmitted to the next cohort of larval ticks. Due to this potentially long period between infection and transmission, Borrelia has to evolve mechanisms that allow it to persist inside the vertebrate hosts (e.g. VlsE-mediated antigenic variation)  ADDIN EN.CITE []. 

1.3: Immune evasion strategies 
The interaction between vertebrate host and Borrelia starts during the blood meal of a nymphal tick. At this stage of its life cycle, it has to escape destruction by the innate immune response. Particularly important is its ability to evade the complement system of the vertebrate host [, ]. Most of the Borrelia-infected nymphs bite hosts that are previously immunized against these pathogens. The ability to super-infect vertebrate hosts with pre-existing acquired immunity against Borrelia is presumably the reason behind greater variability of the ospC gene  ADDIN EN.CITE []. Once Borrelia manages to disseminate throughout the host organism, it has to survive against a strong antibody response. The VlsE antigen plays a critical role in allowing Borrelia to evade acquired immunity and live in the vertebrate host  ADDIN EN.CITE [, ].  
2: Immunological maneuver to cope host defense:  
2.1: Launching of Borrelia into mammalian host: 
At the bite spot, Borrelia must evade host defense strategies to survive and persist in the host. Host defense strategies include antibody-mediated destruction, release of chemokines, production of ROS (reactive oxygen species) (ISL 1373), complement activation (ISAC and SALP20), Chemotaxis of neutrophils (Sialostatin L) and T cell priming  ADDIN EN.CITE [, ]. Salp15, a tick salivary protein, is reported to play a significant role in subverting host defense mechanisms []. It acts by inhibiting CD4 T-cell activation  ADDIN EN.CITE [] and binding to OspC thus steering the prevention from antibody and complement-mediated killing of Borrelia  ADDIN EN.CITE [, ]. Salp25D, another member of tick salivary proteins, neutralizes the impact of ROS produced by neutrophils  ADDIN EN.CITE []. Transmission of Borrelia from ticks was prevented when they were fed on OspC-immunized mice suggesting that OspC functions in a tick-to-host transmission mechanism [, ]. It is generally believed that OspC is needed to evade host innate defenses within the skin. Given that ospC-negative spirochetes are cleared from the site of infection when bacteria are administered by needle, the protective function of OspC for dissemination is independent of SALP15 [].
Tick salivary proteins inhibit macrophage and dendritic cells activation. These proteins also suppress chemokines, cytokine production [] and inhibit recruitment of granulocytes at the bite site  ADDIN EN.CITE [, ]. Several of these proteins interfere with complement activation, particularly alternative pathway which possibly promotes transmission of this pathogen []. A direct effect of these proteins on mast cells is also reported; mast cells inhibition is facilitated by sialostatin L  ADDIN EN.CITE []. Sialostatin L inhibits IL-9 induction, a key regulator of pathogen-induced immune responses  ADDIN EN.CITE []. 
2.2: Evasion of initial sensing inside host:
Within the mammalian host, first detection of B. burgdorferi takes place by virtue of pattern recognition receptors, Toll-like receptors (TLRs) and NOD-like receptors (NLRs) that reside on various cells of the immune system, including dendritic cells and macrophages present in the dermis  ADDIN EN.CITE []. Attachment of Borrelial lipoprotein to TLR2–TLR1  ADDIN EN.CITE [, ] allows for the activation of various processes such as mitogen activated protein kinase (MAPK) pathways, nuclear translocation of NF-κB (Nuclear factor) ensuing the production of inflammatory mediators []. Polymorphism at TLR2 was found associated with Borrelia infection in a wild rodent population  ADDIN EN.CITE []. On the other hand supplementary TLRs such as TLR9, TLR8, TLR7 and TLR5 help TLR2–TLR1 to perform their function  ADDIN EN.CITE []. The motile nature of Borrelia plays a crucial role in its escape. B. burgdorferi moves at a speed of about 4 μm/sec in tissue [] that enables Borrelia to avoid ingestion by phagocytes []. TLR-mediated pattern recognition may be altered/impeded by pathogenic bacteria. Three known phenomena of TLR-mediated escapes include TLR2-induced immunosuppression by stimulating the release of interleukin (IL)-10, TLR recognition blockage and TLR-mediated induction of viral replication. 
 2.3: Complement hang-up:
Innate immunity plays a role by facilitating the antibody independent complement (alternative) pathway; it exploits specific proteins to order phagocytes for their apt role. Certain proteins present on cell surfaces of host cells control the complement pathway. B. burgdorferi binds to factor H or a host complement inhibitor protein called FHL-1/reconectin by virtue of surface-exposed lipoproteins which include OspEs and p21  ADDIN EN.CITE [, ]. Further investigation reveals that B. burgdorferi has another protein with an aptitude to bind the factor H called BbCRASP-1, -2, and -3 []. 
Inactivation of C3b, a key element of the complement system is thought to be the possible cause of complement resistance []. For the duration of tick feeding, expression of some genes, like erp, that encode a vital Borrelial protein (H-binding proteins) is enhanced  ADDIN EN.CITE []. In various genospecies of B. burgdorferi, the C terminal of Erp protein present at exposed region plays key role in binding of factor H, and is associated with resistance to serum-mediated killing inside host  ADDIN EN.CITE [, ]. Inactivation of C3, an important component of the complement system which fights against spirochete infection, and several other factors also play role in innate immunity escape []. Role of CD59 to restrain development of membrane attack complex (MAC) that encompasses cellular destruction has been established. Some Borrelia species acquire a component that has antigenic resemblance to host protein CD59, which binds with C9 (a membrane attack complex molecule)  ADDIN EN.CITE []. 
Complement regulator-acquiring surface proteins (CRASPs)
For pathogen clearance, the host acts with its first line of innate immune defense i.e. the complement system. Complement activation directs the destruction of bacteria through opsonization by coating these pathogens by various opsonizing molecules like C1q, C3b, and iC3b. Commencement of this pathway may be through direct activation of either of the complement pathways (classical or alternative pathways). Generally Gram-negative bacteria are removed by the complement membrane attack complex (MAC). However, these microorganisms are able to counterattack. Requisition of host complementary regulators of the alternative pathway and thus inhibition of complement activation process is a potential method of evasion by pathogens from the host defense system []. B. burgdorferi is equipped with five discrete surface proteins named as CRASP-1, 2, 3, 4 and 5 exhibit the adhering tendency for immune mediators of the host []. Molecules such as Factor H and factor H like protein- 1 (FHL-1/reconnectin), two key fluid-phase complement regulators of alternative pathway, are the prime target of CRASPs binding. Inactivation of C3b may be achieved by this particular binding. Nomenclature of CRASPs has been established on the basis of their species of origin e.g. Bb for B. burgdorferi and Ba for B. afzelii. Proteins of both these species demonstrate similar binding pattern []. A strong interaction has been observed between BbCRASP-1, BbCRASP-2, BaCRASP-1, and FHL-1/reconectin. Simultaneously these proteins show a weak relation with factor H []. Unlike these observations, residual CRASPs of both B. burgdorferi (BbCRASP-3, 4 and 5) and B. afzelii (BaCRASP-4 and 5) attached to the H-factor but not to the FHL-1. Complement regulatory function of components (FHL- 1/reconnectin and factor H) is not perturbed by CRASP proteins []. This property hinders the production of various cytolytic products on the Borrelial surface that may hamper the complement activation. Another protein with tendency to bind complement inhibitory factor H is known as Erp proteins. Similar to CRASPs, various Erp proteins such as OspE, OspF, [] Elps,22 p21, ErpA, and ErpP [] also interact with complement mediators []. Various Erp proteins display special affinity to complement inhibitors. Since there are many Erp proteins present on B. burgdorferi surface so it may help this pathogen to defy complement-mediated killing []. In addition to factor H, B. burgdorferi binds to some other proteins of tick complement system and may avoid the complement-mediated lysis []. Consequently, complement resistance is one of the major characteristics reasons supporting spirochetes transmission to a susceptible host. 
2.4: Anti-inflammatory cytokines: 
B. burgdorferi mires cell-mediated immune (CMI) responses more efficiently than host humoral immune response. Borrelia triggers production of interleukin 10, an anti-inflammatory cytokine. IL-10 produced from monocytes and lymphocytes is a central precursor of cytokine release. Stimulated IL-10 production in peripheral blood mononuclear cells (PBMCs) of uninfected monkey and human is one of the sources to resolve early infection  ADDIN EN.CITE []. Some cellular components of Spirochaetes such as lipoproteins are responsible for such activities as well []. A study conducted using disease resistant C57BL/6 and susceptible C3H/HeN mice described the dual role of IL-10 in pathogenesis of borreliosis. Susceptible mice showed significant arthritis compared to resistant ones []. This trend in resistant mice may be due to over-expression of IL-10 from macrophages. Undeniably, the severity of arthritis and low numbers of spirochete were very much apparent in the joints of IL-10-deficient (C57BL/6) mice []. For this reason, IL-10 actually must have a primitive role in hampering the host response to B. burgdorferi infection. It does this by decreasing the production of tumor necrosis factor alpha (TNF α) and limiting the release of interferon gamma (IFN γ) []. These findings were further discerned in PBMCs of donors that were exposed to B. burgdorferi. Moreover, results were also illustrated by comparing cytokines production in patients of Lyme borreliosis and controls. IL-10 and TLR-2 were shown to play a vital role in this aspect particularly IL-10 has primitive role in the production of pro-inflammatory cytokine and has a strong association with susceptibility of disease []. IL-10 is considerably proficient and causes reduction in the production of cytokine mainly pro-inflammatory in C57BL/6 as compared to C3H/HeN mice []. These findings suggest that susceptibility to Lyme disease might be influenced significantly by lymphocyte response to IL-10 as compared to production of IL-10 by immune cells [].
2.5: Immune complexes
One important aspect of B. burgdorferi is to combine soluble antigens with host antibodies. To validate this concept investigations have been conducted on blood samples of sero-negative patients of Lyme borreliosis and in cerebrospinal fluid collected from the neuro-borreliosis patients  ADDIN EN.CITE [, ]. These studies revealed that antibody complexes were found during the examination of serum in 95 % patients of Lyme borreliosis while 69 % patients previously examined for Borrelia infection with other immunological diagnostic tools were found to have immune complexes. Another supporting study found that 95 % patients with erythema migrans were positive for immune complexes []. But these immune complexes were absent after successful treatment of the patients.  These complexes were also observed for their reactivity of antigen and antibodies. Therefore, one serologic tool to detect these immune complexes in Lyme borreliosis seronegative patients was crafted []. Startlingly, the antibodies against OspA (outer surface protein A) are not normally detectable during early phase of infection. Although OspA is down-regulated in early infection, immune complexes against OspA were observed during early course of experimental infection [].
3: Molecular mechanisms:   
3.1: Outer surface proteins (Osps)
Borrelia expresses a number of outer surface lipoproteins i.e., OspF, OspE, OspD, OspC, OspB and OspA [, ]. Since, OpsE, OspF, OspC, and OspA are surface-exposed, their surface localization on OM is “default”  ADDIN EN.CITE []. Since Osps like Osp C, E and F are up regulated during tick feeding, transmission and migration of Borrelia  ADDIN EN.CITE [, ]. Conversely, other proteins such as OspA, B are down regulated during this course of Borrelial cycle. Plasmids of Borrelia encode several proteins []. Despite the fact that B. burgdorferi are devoid of lipopolysaccharide [], Osps tend to have a strong stimulatory capability on the cells of mammalian host [] and hence leads to inflammation. OspA has extensively been studied and it has been shown in vitro that OspA expressed significantly during dormant period of Borrelial cycle in ticks vector []. OspA plays a wider role for B. burgdorferi within the tick gut. Cells of tick gut digest blood by means of endocytosis. Internalization of B. burgdorferi could be averted due to OspA-mediated attachment of Borrelia to gut cells of the tick []. Some studies have suggested that OspA is not fully down regulated until spirochetes are transmitted to the host  ADDIN EN.CITE [, ]. Borrelia migrates from the tick midgut to the tick salivary glands during the blood meal of nymphal tick. A study demonstrated the relation of B. burgdorferi and OspA. Serum from mice immunized with OspA can kill Borrelia in BSK (Barbour-Stoenner-Kelly) culture or in blood-feeding ticks. OspA were not produced by the spirochaetes after adaptation in host []. These results were further validated by performing an in-vivo investigation on B. burgdorferi by using dialysis membrane chambers []. Osp variable expression leads to heterogeneous pattern among different strains of population, which is observed throughout the course of blood meal. Subsequent to transmission, the function of OspA in the host is unknown. Immune cells particularly T lymphocytes along with antibodies specific to OspA showed an association with both early as well as late/chronic stages of Borrelia infection. Findings of this study confirmed the presence of OspA within the host during the later stages of infection []. Synthesis of OspC, another outer surface protein involved in in host and agent interaction, helps in relocation of Borrelia from tick gut to its salivary gland suggesting that OspC has a susceptive role in the transmission of Borrelia from vector to host []. During early phase of Borrelia infection, immediate response against OspC is reported frequently  ADDIN EN.CITE []. A single copy of OspC gene is present in every B. burgdorferi cell []. Moreover cp32 plasmid of various spirocheates contains many Erp operons  ADDIN EN.CITE [, ]. Clonal population of Borrelia have revealed about ten members of cp32 plasmids have been confirmed []. Complete inventory of Erp might be expressed by a bacterium concurrently []. Various genes of erp family are elp, pG, p21, ospE, ospF, bk2 and Osp related genes []. These flanked genes i.e. UHB are highly conserved upstream sequences at the 5’-end and encode a number of highly polymorphic lipoproteins  ADDIN EN.CITE [, ]. The UHB nomenclature is pre-genomic and reflects our limited knowledge of sequence conservation within cp32 plasmids at the time. The UHB region is not linked with regulation of erp paralogous genes. Studies have shown that these genes are regulated by at least two different sigma factors, the housekeeping sigma factor (RpoD) and the alternate sigma factor, RpoS  ADDIN EN.CITE [, ]. Such polymorphic proteins that are encoded by UHB have a contributive role in immune evasion. Erp genes present a substantial range of variation in sequences in a single bacterium []. Erp of B. burgdorferi 297 have been classified into three distinct factions: OspE and OspF-related homologous gene sequences and Elps holding OspE/F-like leader proteins []. Due to lack substantial data on Erp null mice, it is difficult to ascertain the exact contribution of this protein in infection. 
3.2: Strategies of antigenic variation and immune escape
One popular approach to distinguish strains is to study various immunodominant elements/antigens of pathogen. Immune response of the host is dependent on these antigens. Variants of B. burgdorferi express various ospCs in rodents. Despite the presence of single ospC gene copy, pathogens may be selected on the basis of immune responses generated by host against ospC []. This particular character to elicit a diversified immune response by immunodominant antigens of various strains of the same pathogen is termed ‘antigenic variation’. Specific adaptive immune response is also raised against infected host due to the original serotype of the pathogen. However this specific immune response might not be effective against new strains of the pathogen [].
Genetic recombination adds into antigenic variation:
B. burgdorferi possesses one more crucial mean of antigenic variation for its survival called ‘genetic recombination’. This recombination takes place on a special kind of gene locus known as variable major protein like sequence E (vlsE) []. There are three distinct domains that code a 34 kDa surface protein; two constant regions at the N- and C- terminus and an inner variable segment  ADDIN EN.CITE [, ]. Certain sequence changes produced during infection modifies the vlsE antigenic characteristics. Novel antigenic variants are produced by means of recombination accompanied by the exchange of DNA cassettes. This recombination may play a vital role in immune evasion especially from antibody-mediated immune response elicited against vlsE variant produced during disease  ADDIN EN.CITE []. The right telomeric end of lp28-1 and upstream 15 silent cassettes are sites for single vlsE []. Loss of vlsE bearing lp28-1 and lp25 plasmids leads to reduction in the infectivity of B. burgdorferi B31 strain, indicating that these plasmids may code virulence factors. Variants of vlsE come through unidirectional events of genetic conversion that occur between vlsE locus and upstream silent cassettes []. During tick feeding, this process of recombination starts at vlsE locus  ADDIN EN.CITE []. Analysis of 3-D structure of vlsE protein reveals that variable regions are the principal components of distal outer part of vlsE. These outer surface variable regions might mask invariant regions present in this particular protein. B. burgdorferi may sidestep host immune system by developing numerous vlsE variants that are unable to bind well to specific antibodies elicited by the host against previous VlsE antigenic protein []. VlsE gene expression is down regulated during tick feeding while it is upregulated at the time of infection [].
Lateral gene transfer
The role of bacteriophages in lateral gene transfer and their association with a range of spirochaetes including Borrelia is well recognized. In vitro packaging of a bacteriophage and cp32 (32-kb circular plasmids) of B. burgdorferi has been reported. This method is used to transduce circular plasmid to various strains of Borrelia []. This shift of plasmid DNA from one spirochete to another by means of a phage particle may be a crucial phenomenon of pathogenesis. ospC gene is transferred among same or various strains of Borrelia []. A study compared observations of ospC gene from B. burgdorferi sensu lato []. It was observed that B. valaisiana and B. garinii showed significant ospC gene transfer, similar observations were made for B. valaisiana and B. afzelii []. Frequency of gene exchange between various species of Borrelia may be depicted by an instantaneous infection of two different species of Borrelia []. Spirochaetes may use this plan of gene exchange to show efficient response against environmental selection pressures  ADDIN EN.CITE []. 
Surface proteins polymorphism
Antigenic variation due to various molecular changes in surface protein facilitates the survival of the pathogen []. Since ospA has no relation with vertebrate host immune selection pressure, some heterogeneity has been observed in OspA []. Antigenically sspC is more polymorphic as compared to ospA  ADDIN EN.CITE []. Various means that derive the diversity of ospC include gene transfer, gene recombination, antigenic variation, immunological selection and numerous environmental factors. Selection pressure enforces ospC variation []. To run off the host immunological selection, Borrelia may alter its gene sequence of ospC, and escort the ospC gene variation. Conversely, erp gene stays unchanged in different strains of spirochetes. Re-isolation of Borrelial Erp locus from laboratory animal model after one year of infection showed that erp gene exhibits significant stability during whole course of infection of mammal host []. On the other hand, a validation made on the basis of ospE gene family sequence alignments of numerous Borrelial variants showed that ospE gene family of Borrelia had certain hypervariable regions. This precedent indicated that various molecular processes may have some kind of influence in evolution []. Numerous gene families of Lyme borreliosis spirochetes have a vital role in enhancement of antigenic diversity during the course of infection in reservoirs or host. Different mechanisms used by these gene families include genetic variation, recruitment of closely related genes i.e. erp, genetic change and differential expression of gene families  ADDIN EN.CITE [, ]. 
3.3: Tissue localization of B. burgdorferi:
B. burgdorferi has several locations such as cytosol of joint cells, bradytrophic tissue or cell membrane invaginations. Localization of B. burgdorferi in these tissues may have a critical role in immunity and chemotherapeutic resistance []. Circulating cells like peripheral blood fibrocytes, subpopulation of leukocytes, have a great affinity to Borrelia []. It has been shown in vitro that B. burgdorferi binds with these fibrocytes, resides in the cell membrane invaginations and bypass the phagocytosis []. Further evidences like resistant to ceftriaxone-treated fibroblast cultures support the notion that B. burgdorferi subsists against host defense and antibiotics too [].
B. burgdorferi may exploit human synovial cells for intracellular persistence after exceeding the endothelial fence []. Endothelial receptors mediate that internalization of B. burgdorferi into the endothelial cells []. Some studies suggested that if somehow opsonization of B. burgdorferi could be avoided, then it might go into the macrophages very quickly, which may cause the degradation but it may also leads to intracellular persistence []. Probably, this persistency inside the macrophages is one of the reasons of repeated occurrence of Lyme disease. Intracellular existence of spirochaete in cardiac myocytes was also reported using a murine model []. In contrast to these in vivo and in vitro evidences suggesting intracellular persistence of Borrelia, infrequent reports showed their extracellular existence using samples from patients or human tissues. Extracellular localization of Borrelia in bradytrophic tissue of Lyme disease patients like ligaments and collagen tissue was observed  ADDIN EN.CITE []. A significant high detection rate of B. burgdorferi was observed by performing DNA analysis of synovial fluid or tissue samples of the infected individuals []. However, PCR of synovial tissue biopsies did not confer any potential evidence about intracellular or extracellular location of B. burgdorferi. However, B. burgdorferi was found in various tissues other than joints with extracellular localization  ADDIN EN.CITE [, ]. B. burgdorferi likes to live extracellularly. Since accessibility to spirochetes in affected tissues is difficult, advanced and supplementary are needed to spell out the facts about persistency of spirochetes in future.
Conclusion:
In general, B. burgdorferi is known as an extracellular pathogen associated with a stringent host immune response in terms of antibodies. Since immune evasion strategies of this organism are so diverse, regardless of killing by antibodies, this pathogen survives in such adverse environments []. Any of these strategies alone may not be sufficient for pathogen survival. A colossal database, including the current review, is available on this important issue. However, many conundrums still remain for borreliologists. This review assists in the molecular understanding of Lyme disease pathogenesis that will aid borreliologists in the development of efficient control strategies for this deadly disease. Perhaps it is not that easy to abolish these pathogens from nature but shrinking their menace to a more manageable level is attainable.



Future perspectives:
The host immune system has a key role in defining the transmission and distribution of Borrelia infection. However various essential determinants of Borrelia used by this pathogen to evade the host defense require further investigations. Of note, a comprehensive biochemical analysis should be performed by employing various next generation tools that would help further characterization and quantification of protein-protein interactions of this pathogen. Thorough proteome studies of Borrelia would be useful for discovery and identification of novel potential determinants of spirochetes. B. burgdorferi is deficient in conventional virulence factors like secretion systems and toxins. For that reason, queries such as how Borrelia causes infection, colonizes the vector and escapes host immune response need to be answered. Although single gene deletions have been studied to identify various vital proteins of this bacterium, a comprehensive genomics and proteomics approach will be beneficial in detecting various virulence factors. Another important concern is the association of superinfection and life cycle of Borrelia that is still an unanswered question. Future experiments focusing on the mechanisms involved in secondary infections would provide a better description of immune escape by this spirochete. Furthermore, this field of provokes a strong reason for the collaboration among microbiologists, immunologists, evolutionary biologists and ecologists.
Executive Summary:
	Borrelia burgdorferi sensu lato is a complex consisting of different Borrelia species and causes a disease known as Lyme borreliosis/Lyme Disease. 
	This spirochete maintains its complex transmission network with the help of a vector (Ixodes tick) and a competent reservoir vertebrate host.
	Borrelia synthesizes appropriate proteins for two diverse kinds of environment settings i.e. tick vector and the vertebrate host.
	Tick salivary proteins help in dissemination of Borrelia by inhibiting macrophage and dendritic cells’ inhibition. These proteins cause suppression of chemokines and cytokine production.
	TLR signaling is not always favorable for the host; during particular circumstances specific TLR response may help pathogen escape host defense.
	Complement resistance is one of the primary features that helps Borrelia in immune evasion.
	Outer surface proteins of Borrelia are vital virulence factors, immune escape molecules and adaptation elements associated with host-pathogen interaction. 
	Diversity and multifunctionality of surface proteins of this spirochaete are the key factors that assist Borrelia to evade the host immune system. 
	B. burgdorferi follows a critical way of antigenic variation for its persistence known as genetic recombination i.e major protein like sequence E (vlsE) mediated immune avoidance.
	Borrelia may use lateral gene transfer/gene exchange to express efficient response against the environmental selection pressures.
	The precise knowledge about the immune escape mechanisms of Borrelia may be of help for borreliologists to design preventive strategies against this persistent disease.
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Fig: 1 Genomic orchestrate:
A: Circular chromosomal map of B. burgdorferi. Various rings are included from outwards to inwards 1: All the genes / ORFs on positive strands, 2: Different important ORFs with a distinct colour i.e. Starting from Black: Glpf; Red: Glycerol kinase; Yellow: 0243 & 0368; Green: Lipoprotein; Light blue: bmpB; Orange: bmpA; Pink: napA; Purple: Coenzyme A; Grey: Sensory histidine kinase; Blue 0419, 05688 & 0570; Light green: Periplasmic protein; Green: 0363; Red: 0374; Orange: 0603; Blue: 0647; Yellow: 0184; Purple: 0763; Orange: 0771; Red: 0827, 3: Red circle shows G+C content percentage, 4: Blue circle shows GC skew, 5: Orange circle shows AT skew, 6: Purple circle shows ORFs on the minus strand, 7: Black circle for background shading. This picture is crafted with the help of available online software known as CiVi. [165] 
B: Circular map of plasmid cp26. The various rings are included from outwards to inwards 1: All the genes / ORFs on positive strands, 2: Different important ORFs with a distinct colour i.e. Starting from Black: BB_B03; Red: BB_B19; Yellow: BB_B18; Blue: BB_B17, 3: Red circle shows G+C content percentage, 4: Blue circle shows GC skew, 5: Orange circle shows AT skew, 6: Purple circle shows ORFs on the minus strand, 7: Black circle for background shading. This picture is crafted with the help of available online software known as CiVi. [165] 


Figure 2: Gene regulation in Borrelia burgdorferi
Figure presenting the RpoS regulation, showing the bacterial transcriptional factor i.e. σ-factor RNA polymerase, Rrp1 (response regulatory protein 1) and Hk1 (Histidine Kinase 1). Downstream to the ligand binding with D1 and D2 (Sensor domains present in periplasmic space) of Hk1, a multi-stage phosphorylation process starts which in result activates Rrp1, it steers the production of c-di-GMP (cyclic di-GMP) []. Degradation of c-di-GMP by PdeA and PdeB (Phosphodiesterases) into (pGpG) and GMP is also the crucial part of the process []. 
Although real interaction between Activated Rrp2, BosR (Borrelia oxidative stress regulator) and RpoN is yet to be solved, they initiate the rpoS transcription as a trimeric composite  ADDIN EN.CITE []. Figure shows binding site (BSs) of BosR and RpoN with direct repeat sequence of TAAATTAAAT and TGCAAAAACTGTGCCA (−12/−24). Subsequently to the RpoS transcription various gene prerequisite for Borrelia during the host phase are expressed, while genes expressed during tick phase are suppressed. Furthermore, various genes are presented in the figure 2 with (+/-) their structure include OspA, OspC, OspE (Unresolved), BBA74 (Unresolved).


Fig 3: 3D protein structures of selected (structurally resolved) proteins of B. burgdorferi
A: OspC (PDB: 1GGQ); B: BBK32 (BDP: 4PZ5); C: OspA (PDB: 1OSP); D: ErpP (PDB: 4BOB)
E: dbpB (PDB: 2MVG); F: p35 (PDB: 4ALY); G: CRASP-1 (PDB: 5A2U); H: CRASP-4 (PDB: 4CBE)



Table 1: Description of principal genes associated with the endurance of B. burgdorferi



Sr. No.	Operons	Genes ID	Protein Encoded 	Position in Operon	Pfam	Domain Description 	Function	References
1   	bbu-BB0240   	BB0240	glycerol uptake facilitator (GlpF)	1	PF00230	Major intrinsic proteins	Glycerol metabolism in tick 	[]
		BB0241 	glycerol kinase (GlpK) 	2 	PF02782PF00370	FGGY carbohydrate kinase family		
		BB0242	hypothetical protein	3		Uncharacterized protein		
2	bbu-BB0243	BB0243	glycerol-3-phosphate dehydrogenase, anaerobic (GlpA)	1	PF01266	FAD dependent oxidoreductase family		
3	bbu-BB0365	BB0365	lipoprotein La7	1		 	For the Persistence inside the tick vector 	[]
4	bbu-BB0382	BB0382	basic membrane protein B (BmpB)	1	PF02608	Basic membrane protein	Binding to Laminin &Joint infection	[] 
5	bbu-BB0384	BB0383	basic membrane protein A (BmpA)	2				
6	bbu-BB0690	BB0690	neutrophil activating protein (NapA)	1	PF00210	Ferritin-like domain	For the Persistence inside the tick vector 	 ADDIN EN.CITE []
7  	bbu-BB0729  	BB0728  	coenzyme A disulfide reductase  	2  	PF00070PF07992PF02852	Pyridine nucleotide-disulphide oxidoreductase	As a Coenzyme A (Disulfide reductase)and protect the pathogen from oxidative stress	 ADDIN EN.CITE []
8	bbu-BB0420	BB0420	sensory transduction histidine kinase, putative	1	PF00072PF00512PF02518	Response regulator receiver domainTwo-component regulatory systemGHKL domain (Gyrase, Hsp90, Histidine Kinase, MutL)	Hk1 and rrp 1Two-component system perquisite  inside replete tick for the survival 	[]
		BB0419	response regulatory protein (rrp-1)	2	PF00072PF00990	Response regulator receiver domainGGDEF domain		
9	bbu-BB0733	BB0733	hypothetical protein	1		 	PilZ domain having the c-di-GMP effector proteinRequirement of the infection of vector as well as host	[]
10	bbu-BB0360	BB0363	periplasmic protein	4		 	Phosphodiesterase A Responsible for the infection inside mice model	[]
11 	bbu-BB0374 	BB0374 	hypothetical protein 	1 	COG2206 (​http:​/​​/​www.ncbi.nlm.nih.gov​/​Structure​/​cdd​/​cddsrv.cgi?uid=225116​)cd00077 (​http:​/​​/​www.ncbi.nlm.nih.gov​/​Structure​/​cdd​/​cddsrv.cgi?uid=238032​)	HDGYP; HD-GYP domain, c-di-GMP phosphodiesterase class II (or its inactivated variant) [Signal transduction mechanisms]HDc; Metal dependent phosphohydrolases with conserved 'HD' motif	Phosphodiesterase B Perquisite for the transmission of Borrelia from host to vectorNecessary to live inside tick	[] 
12	bbu-BB0603	BB0603	membrane-associated protein P66	1		 	Integrin binding adhesinPorin	[]
13	bbu-BB0647	BB0647	ferric uptake regulation protein (fur)	1	PF01475	Ferric uptake regulator family	Regulator of Bos (Borrelia oxidative stress) Requisite of rpoS transcription	 ADDIN EN.CITE []
14	bbu-BB0180	BB0184	carbon storage regulator (CsrA)	5	PF02599	Global regulator protein family	RNA-binding protein And has an impact in regulation of rpoS at  post-transcriptional level	[]
15	bbu-BB0767	BB0763	response regulatory protein (rrp-2)	5		 	Rrp 2 (Response regulator protein) Wanted by RpoN for rpoS  transcription	[]
16 	bbu-BB0452 	BB0450 	RNA polymerase sigma-54 factor (NtrA) 	3 	PF04963PF04552	Sigma-54 factor, core binding domainSigma-54, DNA binding domain	Alternative σ-factor steers the transcription of rpoS	 ADDIN EN.CITE []
17  	bbu-BB0771  	BB0771  	RNA polymerase sigma factor (RpoS)  	1  	PF00140PF04542PF04545	Sigma-70 factor, region 1.2Sigma-70 region 2Sigma-70, region 4	Alternative σ-factor required for the transcription of the genes involved during host phase of cycle andSuppress the genes of vector phase 	 ADDIN EN.CITE []  
18   	bbu-BB0828   	BB0827   	ATP-dependent helicase (HrpA)   	2   	PF00270PF04408PF00271PF07717	DEAD/DEAH box helicaseHelicase associated domain (HA2)Helicase conserved C-terminal domainOligonucleotide/oligosaccharide-binding (OB)-fold	DEAH-box RNA helicase responsible for the global gene regulation	 []  



Plasmid 	Gene ID	Gene Name	Protein Name	Pfam	Domain Description 	Function	Refrences
cp26     	BB_B03	resT	Telomere resolvase ResT	 	 	Telomere resolvase	[]
	BB_B19	ospC	Outer surface protein C	PF01441	Lipoprotein	Distribution inside mice	[]
	BB_B18  	guaA  	GMP synthase 	PF00117PF00958PF02540	Glutamine amidotransferaseGMP synthaseNAD synthase	GMP synthase and IMPDHAssociated with the Nucleotide salvage especially purine pathways	[]
	BB_B17	guaB	Inosine-5'-monophosphate dehydrogenase	PF00478	IMPDH/GMPR family		
cp32-9	BB_N38	erpP	ErpP protein	PF02471	Borrelia outer surface protein E	BbCRASPs (3, 4, 5) Complement hang upLaminin bindingPlasminogen binding	 ADDIN EN.CITE [, ]
cp32-8	BB_L39	erpA8	ErpA8 protein				
cp32-1	BB_P38	erpA	ErpA protein				
lp25  	BB_E02	BB_H09	Type I restriction enzyme r protein n terminus	PF13588	Type I restriction enzyme R protein N terminus	System of Restriction & modification 	[]
	BB_E16	bptA	 	PF17044	Borrelial persistence in ticks protein A	Persistence inside tick vector	 ADDIN EN.CITE []
	BB_E22	pncA	Pyrazinamidase/nicotinamidase	PF00857	Isochorismatase family	Pyrazinamidase & nicotinamidase	[]
lp28-1	vlsE	vlsE	Vmp-like sequence protein VlsE	PF00921	Borrelia lipoprotein	Recombination network of immune evasion	[]
lp36 	BB_K17	ade	Adenine deaminase	PF13382	Adenine deaminase C-terminal domain	Adenine deaminase	[]
	BB_K32	bbk32	Fibronectin-binding protein BBK32	 	 	Fibronectin-binding protein	[]
lp54       	BB_A15	ospA	Outer surface protein A	PF00820	Borrelia lipoprotein	Vector midgut epithelium colonization	 ADDIN EN.CITE []
	BB_A16	ospB	Outer surface protein B				
	BB_A24	dbpA	Decorin-binding protein A	PF02352	Decorin binding protein 	Dbp (Decorin-binding proteins)	[]
	BB_A25	dbpB	Decorin-binding protein B				
	BB_A52	BB_A52	Putative outer membrane protein BBA52	 	 	Transmission from vector to host	[]
	BB_A62	lp6.6	6.6 kDa lipoprotein 	 	 	Persistence inside ticks	[]
	BB_A64	BB_A64	P35 antigen	PF05714	Borrelia burgdorferi virulent strain associated lipoprotein	Transmission from vector to host	[]
	BB_A68	cspA	Complement regulator-acquiring surface protein 1 			Complement hang up	[]
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